A detailed history of Tfr Capital, Llc. transactions in Amgen Inc stock. As of the latest transaction made, Tfr Capital, Llc. holds 771 shares of AMGN stock, worth $263,458. This represents 0.07% of its overall portfolio holdings.

Number of Shares
771
Previous 805 4.22%
Holding current value
$263,458
Previous $224,000 3.13%
% of portfolio
0.07%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

SELL
$271.18 - $309.22 $9,220 - $10,513
-34 Reduced 4.22%
771 $217,000
Q2 2025

Jul 24, 2025

BUY
$262.28 - $309.85 $19,670 - $23,238
75 Added 10.27%
805 $224,000
Q1 2025

May 01, 2025

BUY
$258.59 - $327.36 $188,770 - $238,972
730 New
730 $227 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tfr Capital, Llc. Portfolio

Follow Tfr Capital, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfr Capital, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Tfr Capital, Llc. with notifications on news.